RY
PHARM
LATEST
RESPIRATORY
GKA2025
APEA-
REVISED
PHARM
LATEST
EXAM
RESPIRATORY
2025
QUESTIONS
REVISED
LATEST
AND
EXAM
CORRECT
2025
QUESTIONS
REVISED
DETAILED
AND
EXAM
CORRECT
ANSWERS
QUESTIONS
DETAILED
(VERIFIED
AND CORRECT
ANSWERS
COMPLETE
DETAILED
(VERIFIED
SOLUTION)
ANSWERS
COMPLETE
ALREADY
(VERIFIED
SOLUTION)
PASSED COMPLETE
SCORE
ALREADY
A+.pdf
SOLUTION)
PASSED SCA
GKA APEA- PHARM RESPIRATORY
LATEST 2025 REVISED EXAM
QUESTIONS AND CORRECT
DETAILED ANSWERS (VERIFIED
COMPLETE SOLUTION) ALREADY
PASSED SCORE A+
Prior to a routine pulmonary function test
Which of the following scenarios would NOT warrant monitoring of a serum
theophylline level?
Exacerbation of chronic bronchitis
New diagnosis of diabetes
Prior to initiating therapy
Prior to a routine pulmonary function test
atorvastatin.
RY LATEST
GKA2025
APEA-
REVISED
PHARMEXAM
RESPIRATORY
QUESTIONSLATEST
AND CORRECT
2025 REVISED
DETAILED
EXAMANSWERS
QUESTIONS
16/01/2026
(VERIFIED
AND CORRECT
COMPLETE
DETAILED
SOLUTION)
ANSWERS
ALREADY
(VERIFIED
PASSED COMPLETE
SCORE A+.pdf
SOLUTION) A
,RY
PHARM
LATEST
RESPIRATORY
GKA2025
APEA-
REVISED
PHARM
LATEST
EXAM
RESPIRATORY
2025
QUESTIONS
REVISED
LATEST
AND
EXAM
CORRECT
2025
QUESTIONS
REVISED
DETAILED
AND
EXAM
CORRECT
ANSWERS
QUESTIONS
DETAILED
(VERIFIED
AND CORRECT
ANSWERS
COMPLETE
DETAILED
(VERIFIED
SOLUTION)
ANSWERS
COMPLETE
ALREADY
(VERIFIED
SOLUTION)
PASSED COMPLETE
SCORE
ALREADY
A+.pdf
SOLUTION)
PASSED SCA
coadministration of a HMG-CoA reductase inhibitor & certain macrolide
antibiotics, like clindamycin, can lead to debilitating myelopathy and rhabdo
In the treatment of pneumonia, a macrolide such as clarithromycin should NOT be
coadministered with:
acetaminophen.
atorvastatin.
furosemide.
propanolol.
guaifenesin.
+ dexamethasone
Robitussin DM is a combination of dextromethorphan and:
benzonatate.
benzocaine.
guaifenesin.
phenylephrine.
relaxing the smooth muscles of the bronchi.
Xanthines such as theophylline, used in the treatment of COPD, cause
bronchodilation by:
blocking the action of acetylcholine.
RY LATEST
GKA2025
APEA-
REVISED
PHARMEXAM
RESPIRATORY
QUESTIONSLATEST
AND CORRECT
2025 REVISED
DETAILED
EXAMANSWERS
QUESTIONS
16/01/2026
(VERIFIED
AND CORRECT
COMPLETE
DETAILED
SOLUTION)
ANSWERS
ALREADY
(VERIFIED
PASSED COMPLETE
SCORE A+.pdf
SOLUTION) A
,RY
PHARM
LATEST
RESPIRATORY
GKA2025
APEA-
REVISED
PHARM
LATEST
EXAM
RESPIRATORY
2025
QUESTIONS
REVISED
LATEST
AND
EXAM
CORRECT
2025
QUESTIONS
REVISED
DETAILED
AND
EXAM
CORRECT
ANSWERS
QUESTIONS
DETAILED
(VERIFIED
AND CORRECT
ANSWERS
COMPLETE
DETAILED
(VERIFIED
SOLUTION)
ANSWERS
COMPLETE
ALREADY
(VERIFIED
SOLUTION)
PASSED COMPLETE
SCORE
ALREADY
A+.pdf
SOLUTION)
PASSED SCA
decreasing the activity of inflammatory mediators.
relaxing the smooth muscles of the bronchi.
stimulating beta 2 receptors.
frequent drug-drug interactions.
When considering the use of theophylline to treat chronic bronchitis, its use is
limited due to:
low-risk profile.
minimal effects on lung function.
wide therapeutic window.
frequent drug-drug interactions.
long-acting bronchodilator and an inhaled corticosteroid.
For asthma symptoms occurring daily with nighttime symptoms greater than one
time per week, the preferred daily treatment is a:
long-acting bronchodilator.
long-acting bronchodilator and an inhaled corticosteroid.
long-acting bronchodilator and a leukotriene receptor antagonist.
high-dose inhaled corticosteroid and theophylline.
RY LATEST
GKA2025
APEA-
REVISED
PHARMEXAM
RESPIRATORY
QUESTIONSLATEST
AND CORRECT
2025 REVISED
DETAILED
EXAMANSWERS
QUESTIONS
16/01/2026
(VERIFIED
AND CORRECT
COMPLETE
DETAILED
SOLUTION)
ANSWERS
ALREADY
(VERIFIED
PASSED COMPLETE
SCORE A+.pdf
SOLUTION) A
,RY
PHARM
LATEST
RESPIRATORY
GKA2025
APEA-
REVISED
PHARM
LATEST
EXAM
RESPIRATORY
2025
QUESTIONS
REVISED
LATEST
AND
EXAM
CORRECT
2025
QUESTIONS
REVISED
DETAILED
AND
EXAM
CORRECT
ANSWERS
QUESTIONS
DETAILED
(VERIFIED
AND CORRECT
ANSWERS
COMPLETE
DETAILED
(VERIFIED
SOLUTION)
ANSWERS
COMPLETE
ALREADY
(VERIFIED
SOLUTION)
PASSED COMPLETE
SCORE
ALREADY
A+.pdf
SOLUTION)
PASSED SCA
Utilize a spacer for administration.
For complaints of dysphonia related to the use of mometasone (Asmanex), the
patient should be advised to:
stop the inhaler immediately.
decrease the dosage.
apply an oropharyngeal analgesic prior to use.
utilize a spacer for administration.
Mycoplasma pneumoniae.
Doxycycline (Vibramycin) is the preferred treatment of pneumonia caused by:
Haemophilus influenzae.
Mycoplasma pneumoniae.
Staphylococcus aureus.
Streptococcus pneumoniae.
moderate persistent asthma in 5-11-year-olds, when combined with low-dose
inhaled steroid.
Long-acting bronchodilators, such as salmeterol (Serevent Diskus), are indicated
in the treatment of:
intermittent asthma in patients 12 years and older.
RY LATEST
GKA2025
APEA-
REVISED
PHARMEXAM
RESPIRATORY
QUESTIONSLATEST
AND CORRECT
2025 REVISED
DETAILED
EXAMANSWERS
QUESTIONS
16/01/2026
(VERIFIED
AND CORRECT
COMPLETE
DETAILED
SOLUTION)
ANSWERS
ALREADY
(VERIFIED
PASSED COMPLETE
SCORE A+.pdf
SOLUTION) A
PHARM
LATEST
RESPIRATORY
GKA2025
APEA-
REVISED
PHARM
LATEST
EXAM
RESPIRATORY
2025
QUESTIONS
REVISED
LATEST
AND
EXAM
CORRECT
2025
QUESTIONS
REVISED
DETAILED
AND
EXAM
CORRECT
ANSWERS
QUESTIONS
DETAILED
(VERIFIED
AND CORRECT
ANSWERS
COMPLETE
DETAILED
(VERIFIED
SOLUTION)
ANSWERS
COMPLETE
ALREADY
(VERIFIED
SOLUTION)
PASSED COMPLETE
SCORE
ALREADY
A+.pdf
SOLUTION)
PASSED SCA
GKA APEA- PHARM RESPIRATORY
LATEST 2025 REVISED EXAM
QUESTIONS AND CORRECT
DETAILED ANSWERS (VERIFIED
COMPLETE SOLUTION) ALREADY
PASSED SCORE A+
Prior to a routine pulmonary function test
Which of the following scenarios would NOT warrant monitoring of a serum
theophylline level?
Exacerbation of chronic bronchitis
New diagnosis of diabetes
Prior to initiating therapy
Prior to a routine pulmonary function test
atorvastatin.
RY LATEST
GKA2025
APEA-
REVISED
PHARMEXAM
RESPIRATORY
QUESTIONSLATEST
AND CORRECT
2025 REVISED
DETAILED
EXAMANSWERS
QUESTIONS
16/01/2026
(VERIFIED
AND CORRECT
COMPLETE
DETAILED
SOLUTION)
ANSWERS
ALREADY
(VERIFIED
PASSED COMPLETE
SCORE A+.pdf
SOLUTION) A
,RY
PHARM
LATEST
RESPIRATORY
GKA2025
APEA-
REVISED
PHARM
LATEST
EXAM
RESPIRATORY
2025
QUESTIONS
REVISED
LATEST
AND
EXAM
CORRECT
2025
QUESTIONS
REVISED
DETAILED
AND
EXAM
CORRECT
ANSWERS
QUESTIONS
DETAILED
(VERIFIED
AND CORRECT
ANSWERS
COMPLETE
DETAILED
(VERIFIED
SOLUTION)
ANSWERS
COMPLETE
ALREADY
(VERIFIED
SOLUTION)
PASSED COMPLETE
SCORE
ALREADY
A+.pdf
SOLUTION)
PASSED SCA
coadministration of a HMG-CoA reductase inhibitor & certain macrolide
antibiotics, like clindamycin, can lead to debilitating myelopathy and rhabdo
In the treatment of pneumonia, a macrolide such as clarithromycin should NOT be
coadministered with:
acetaminophen.
atorvastatin.
furosemide.
propanolol.
guaifenesin.
+ dexamethasone
Robitussin DM is a combination of dextromethorphan and:
benzonatate.
benzocaine.
guaifenesin.
phenylephrine.
relaxing the smooth muscles of the bronchi.
Xanthines such as theophylline, used in the treatment of COPD, cause
bronchodilation by:
blocking the action of acetylcholine.
RY LATEST
GKA2025
APEA-
REVISED
PHARMEXAM
RESPIRATORY
QUESTIONSLATEST
AND CORRECT
2025 REVISED
DETAILED
EXAMANSWERS
QUESTIONS
16/01/2026
(VERIFIED
AND CORRECT
COMPLETE
DETAILED
SOLUTION)
ANSWERS
ALREADY
(VERIFIED
PASSED COMPLETE
SCORE A+.pdf
SOLUTION) A
,RY
PHARM
LATEST
RESPIRATORY
GKA2025
APEA-
REVISED
PHARM
LATEST
EXAM
RESPIRATORY
2025
QUESTIONS
REVISED
LATEST
AND
EXAM
CORRECT
2025
QUESTIONS
REVISED
DETAILED
AND
EXAM
CORRECT
ANSWERS
QUESTIONS
DETAILED
(VERIFIED
AND CORRECT
ANSWERS
COMPLETE
DETAILED
(VERIFIED
SOLUTION)
ANSWERS
COMPLETE
ALREADY
(VERIFIED
SOLUTION)
PASSED COMPLETE
SCORE
ALREADY
A+.pdf
SOLUTION)
PASSED SCA
decreasing the activity of inflammatory mediators.
relaxing the smooth muscles of the bronchi.
stimulating beta 2 receptors.
frequent drug-drug interactions.
When considering the use of theophylline to treat chronic bronchitis, its use is
limited due to:
low-risk profile.
minimal effects on lung function.
wide therapeutic window.
frequent drug-drug interactions.
long-acting bronchodilator and an inhaled corticosteroid.
For asthma symptoms occurring daily with nighttime symptoms greater than one
time per week, the preferred daily treatment is a:
long-acting bronchodilator.
long-acting bronchodilator and an inhaled corticosteroid.
long-acting bronchodilator and a leukotriene receptor antagonist.
high-dose inhaled corticosteroid and theophylline.
RY LATEST
GKA2025
APEA-
REVISED
PHARMEXAM
RESPIRATORY
QUESTIONSLATEST
AND CORRECT
2025 REVISED
DETAILED
EXAMANSWERS
QUESTIONS
16/01/2026
(VERIFIED
AND CORRECT
COMPLETE
DETAILED
SOLUTION)
ANSWERS
ALREADY
(VERIFIED
PASSED COMPLETE
SCORE A+.pdf
SOLUTION) A
,RY
PHARM
LATEST
RESPIRATORY
GKA2025
APEA-
REVISED
PHARM
LATEST
EXAM
RESPIRATORY
2025
QUESTIONS
REVISED
LATEST
AND
EXAM
CORRECT
2025
QUESTIONS
REVISED
DETAILED
AND
EXAM
CORRECT
ANSWERS
QUESTIONS
DETAILED
(VERIFIED
AND CORRECT
ANSWERS
COMPLETE
DETAILED
(VERIFIED
SOLUTION)
ANSWERS
COMPLETE
ALREADY
(VERIFIED
SOLUTION)
PASSED COMPLETE
SCORE
ALREADY
A+.pdf
SOLUTION)
PASSED SCA
Utilize a spacer for administration.
For complaints of dysphonia related to the use of mometasone (Asmanex), the
patient should be advised to:
stop the inhaler immediately.
decrease the dosage.
apply an oropharyngeal analgesic prior to use.
utilize a spacer for administration.
Mycoplasma pneumoniae.
Doxycycline (Vibramycin) is the preferred treatment of pneumonia caused by:
Haemophilus influenzae.
Mycoplasma pneumoniae.
Staphylococcus aureus.
Streptococcus pneumoniae.
moderate persistent asthma in 5-11-year-olds, when combined with low-dose
inhaled steroid.
Long-acting bronchodilators, such as salmeterol (Serevent Diskus), are indicated
in the treatment of:
intermittent asthma in patients 12 years and older.
RY LATEST
GKA2025
APEA-
REVISED
PHARMEXAM
RESPIRATORY
QUESTIONSLATEST
AND CORRECT
2025 REVISED
DETAILED
EXAMANSWERS
QUESTIONS
16/01/2026
(VERIFIED
AND CORRECT
COMPLETE
DETAILED
SOLUTION)
ANSWERS
ALREADY
(VERIFIED
PASSED COMPLETE
SCORE A+.pdf
SOLUTION) A
